BioNexus Gene Lab Corp.
$1.55
+0.05 (+3.33%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +17.4%
- 3 Months
- -33.2%
- YTD
- -60.8%
- 1 Year
- -72.3%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 73.8%
- Largest decline max drawdown, since Aug 2025
- -78.0%
- Risk-adjusted return Sharpe ratio, 1-year
- -1.37
Own BGLC?
See how BGLC contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.